Brexit: 'No guarantee' of medicines if no EU deal agreed

14 July 2019 - Scottish Brexit Secretary Mike Russell has said he cannot absolutely guarantee the supply of medicine to ...

Read more →

New treatment approved for patients with breast cancer in Scotland

8 July 2019 - A new drug for patients with advanced breast cancer has been approved for use by the ...

Read more →

SMC - July 2019 decisions

8 July 2019 - A medicine used to treat advanced breast cancer has today been accepted by the Scottish Medicines ...

Read more →

SMC - June 2019 decisions

10 June 2019 - The Scottish Medicines Consortium, which advises on newly licensed medicines for use by NHSScotland, has today ...

Read more →

New cancer drugs approved for NHS use in Scotland

13 May 2019 - The Scottish Medicines Consortium accepted the use of new medicines to treat patients with breast and skin ...

Read more →

SMC - May 2019 decisions

13 May 2019 - A medicine used to treat advanced breast cancer has today been accepted by the SMC for ...

Read more →

Keeping up the PACE at the Scottish Medicines Consortium

26 March 2019 - There are many ways that patient centricity could be delivered when doing a health technology assessment. ...

Read more →

SMC says ‘no’ to Novartis’ Kymriah for adults with lymphoma

11 March 2019 - Adults with lymphoma will not be able to access Novartis’ CAR-T therapy Kymriah on the NHS ...

Read more →

SMC - March 2019 decisions

11 March 2019 - The Scottish Medicines Consortium has today published advice accepting two new medicines. ...

Read more →

They can’t get their medicines. So they’re moving to Scotland.

26 February 2019 - Families in England are preparing to leave the country in a desperate bid to obtain a cystic ...

Read more →

Yescarta rejected among other SMC decisions

12 February 2019 - Gilead's CAR-T therapy Yescarta (axicabtagene ciloleucel) has been rejected by the Scottish Medicines Consortium (SMC) for ...

Read more →

SMC - February 2019 decisions

11 February 2019 - A medicine used to treat a rare blood cancer in children and young adults has today  ...

Read more →

Life-extending drug Perjeta approved for secondary breast cancer

14 January 2019 - A drug used to treat advanced breast cancer has been approved for use on the NHS ...

Read more →

SMC - January 2019 decisions

14 January 2019 - A medicine used to treat advanced breast cancer has today been accepted by the SMC for ...

Read more →

Perjeta given green light in Scotland as early stage breast cancer treatment

10 December 2018 - Hundreds of breast cancer patients are expected to benefit after a sought-after drug was approved for ...

Read more →